Unknown file type. Enclosure URL IS: - http://feedproxy.google.com/~r/BiotechNow/~5/UYBWJs4cu5s/BIO%20Investor%20Forum%20-%20Program%20Schedule.pdf
Summary: Opsona Therapeutics will be participating in the upcoming BIO Investor Forum, and will be giving a presentation on their work in the autoimmune/inflammatory diseases and oncology space (among other indications). To learn more about their company, please read one of our final company snapshots below. Company Snapshot What is your company’s lead product or technology? Opsona’s lead product OPN-305 is a fully humanized monoclonal IgG4 antibody targeting Toll-like-receptor-2 (TLR2), which is in clinical development as Read More
